Kimmel Cancer Center at Jefferson News Releases
-
Kimmel Cancer Center Scientist Elected to Interurban Clinical Club
Published: 04-014-2008
Summary
Michael Lisanti, M.D., Ph.D., has recently been elected membership to the Interurban Clinical Club. This prestigious club was founded by Sir William Osler in 1905 for the purpose of exchanging ideas and fellowship among medical teachers in some of the leading Eastern medical schools.
-
Jefferson Scientists' Discovery May Help Explain Smoking-Pancreatic Cancer Link
Published: 04-014-2008
Summary
Researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia are inching closer to understanding how common blood pressure medications might help prevent the spread of pancreatic cancer. They have found in the laboratory that one type of pressure-lowering drug called an angiotensin receptor blocker inhibits pancreatic cancer cell growth and causes cell death.
-
Neal Flomenberg, M.D., Named Chair of the Department of Medical Oncology at Jefferson
Published: 04-014-2008
Summary
Bone marrow transplant expert Neal Flomenberg, M.D., has been named the new chair of the Department of Medical Oncology at Jefferson Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital and the Kimmel Cancer Center at Jefferson in Philadelphia.
-
Blood Pressure Drugs Halt Pancreatic Cancer Cell Growth, Jefferson Researchers Find
Published: 04-014-2008
Summary
Researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia are inching closer to understanding how common blood pressure medications might help prevent the spread of pancreatic cancer. They have found in the laboratory that one type of pressure-lowering drug called an angiotensin receptor blocker inhibits pancreatic cancer cell growth and causes cell death.
-
Jefferson, PanCAN Holding Program April 5 to Help Patients, Families, and Public Learn More About Pancreatic Cancer
Published: 04-03-2008
Summary
Jefferson's Kimmel Cancer Center and the Pancreatic Cancer Action Network (PanCAN), a national advocacy organization, are sponsoring a pancreatic cancer symposium on Saturday, April 5, 2008 on the Thomas Jefferson University campus.
-
Kimmel Cancer Center Hosts Program to Help Patients and Families Learn More About Living with Cancer April 2
Published: 04-01-2008
Summary
The Kimmel Cancer Center at Jefferson in Philadelphia is holding a program on Wednesday, April 2, 2008 for patients, families and caregivers whose lives have been touched by cancer.
-
Kimmel Cancer Center Scientist Named Editor-in-Chief of Prestigious Pathology Journal
Published: 03-31-2008
Summary
Renowned cell biologist Michael P. Lisanti, M.D., Ph.D., the Margaret Q. Landenberger Professor in Breast Cancer Research at Jefferson Medical College of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson in Philadelphia, has been named Editor-in-Chief of The American Journal of Pathology (AJP). His term begins in July.
-
Jefferson Establishes New Center to Study Stem Cells and Regenerative Medicine
Published: 03-17-2008
Summary
Thomas Jefferson University has established a new center to study the biology, behavior and the potential medical uses of adult stem cells in a variety of diseases, including neurological disease and cancer.
-
Blocking Growth Protein Kills Prostate Cancer Cells, Inhibits Tumor Growth, Jefferson Scientists Find
Published: 02-29-2008
Summary
Researchers at Jefferson's Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer's growth. The work proves that the protein, Stat5, is both vital to prostate cancer cell maintenance and that it is a viable target for drug therapy.
-
New Jefferson Trial to Test Radiation-Emitting Beads Against Advanced Liver Cancer
Published: 02-27-2008
Summary
Liver cancer specialists at Jefferson's Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver's main artery while also blocking the blood supply feeding the cancer's growth.
-
Kimmel Cancer Center Faculty Elected as Secretary of the Association of Cancer Executives (ACE)
Published: 02-27-2008
Summary
Joy Soleiman, MPA, Clinical Administrator of the Kimmel Cancer Center, was elected to a two year term as Secretary of the Association of Cancer Executives (ACE).
-
Jefferson Scientists Uncover Role of Cancer Stem Cell Marker: Controlling Gene Expression Patterns
Published: 02-27-2008
Summary
Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have made an extraordinary advance in the understanding of the function of a gene previously shown to be part of an 11-gene "signature" that can predict which tumors will be aggressive and likely to spread. The gene, USP22, encodes an enzyme that appears to be crucial for controlling large scale changes in gene expression, one of the hallmarks of cancer cells.
- Jefferson Scientists Find Protein Helps Pancreatic Cancer Cells Hide from Immune System, Allowing Spread
- "C" to Believe: Jefferson Scientists Studying the Effects of High Dose Vitamin C on Non-Hodgkin Lymphoma Patients
- Jefferson Scientists Find Cell Growth Protein Potential Drug Target for Treatment-Resistant Prostate Cancer
- Jefferson Scientists Uncover Key Pathway, Potential Drug Targets in Autoinflammatory Disease
- Landenberger Professorship Established at Jefferson
- Jefferson Researchers Discover Key Regulator of Hormonal Signaling in Breast Cancer Cells, Potential Drug Target
- Jefferson Radiation Oncologists to Use Real-Time System to Help Plant “Seeds” Against Prostate Cancer
- Jefferson Researchers Find that Personalized Interventions are Key to Improving Colon Cancer Screening Rates
- Philadelphia Magazine's Top Doctors 2007 - Kimmel Cancer Center at Jefferson
- Jefferson Oncologists Show Breast Cancers to be More Aggressive in African American Women
- Jefferson Radiation Oncologist to Accept ASCO Scientific Leadership Award for RTOG
- JAMA Editorial: Jefferson Pharmacologist Says Biomarker Discovery Bodes Well for Better Cancer Diagnostics, Personalized Medicine
- Jefferson Vaccine Pioneer Hilary Koprowski, M.D., Wins 2007 Sabin Gold Medal





